Abstract
e13031 Background: EDO-S101 combines the DNA damaging effect of bendamustine with the pan-histone deacetylase inhibitor vorinostat. The molecule was tested in models of human MGMT negative and posi...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
